PMC:7377212 / 1118-1846 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T24","span":{"begin":4,"end":25},"obj":"SP_7"},{"id":"T25","span":{"begin":30,"end":38},"obj":"SP_7"},{"id":"T26","span":{"begin":40,"end":45},"obj":"NCBITaxon:10239"},{"id":"T27","span":{"begin":91,"end":102},"obj":"NCBITaxon:1"},{"id":"T28","span":{"begin":159,"end":167},"obj":"SP_7"},{"id":"T29","span":{"begin":194,"end":205},"obj":"UBERON:0001004"},{"id":"T30","span":{"begin":244,"end":249},"obj":"NCBITaxon:10239"},{"id":"T31","span":{"begin":344,"end":355},"obj":"GO:0015671"},{"id":"T32","span":{"begin":404,"end":413},"obj":"NCBITaxon:2"},{"id":"T33","span":{"begin":448,"end":471},"obj":"UBERON:0001558"},{"id":"T34","span":{"begin":472,"end":477},"obj":"NCBITaxon:10239"},{"id":"T35","span":{"begin":550,"end":558},"obj":"SP_7"},{"id":"T36","span":{"begin":568,"end":581},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T37","span":{"begin":616,"end":622},"obj":"NCBITaxon:4751"},{"id":"T38","span":{"begin":651,"end":659},"obj":"SP_7"},{"id":"T39","span":{"begin":671,"end":680},"obj":"UBERON:0002048"},{"id":"T73730","span":{"begin":30,"end":38},"obj":"SP_7"},{"id":"T85102","span":{"begin":40,"end":45},"obj":"NCBITaxon:10239"},{"id":"T81036","span":{"begin":91,"end":102},"obj":"NCBITaxon:1"},{"id":"T16805","span":{"begin":159,"end":167},"obj":"SP_7"},{"id":"T23436","span":{"begin":194,"end":205},"obj":"UBERON:0001004"},{"id":"T90565","span":{"begin":244,"end":249},"obj":"NCBITaxon:10239"},{"id":"T80972","span":{"begin":344,"end":355},"obj":"GO:0015671"},{"id":"T23433","span":{"begin":404,"end":413},"obj":"NCBITaxon:2"},{"id":"T48068","span":{"begin":448,"end":471},"obj":"UBERON:0001558"},{"id":"T57817","span":{"begin":472,"end":477},"obj":"NCBITaxon:10239"},{"id":"T8958","span":{"begin":550,"end":558},"obj":"SP_7"},{"id":"T86360","span":{"begin":568,"end":581},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T64802","span":{"begin":616,"end":622},"obj":"NCBITaxon:4751"},{"id":"T86299","span":{"begin":651,"end":659},"obj":"SP_7"},{"id":"T12819","span":{"begin":671,"end":680},"obj":"UBERON:0002048"}],"text":"The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which may require mechanical ventilation or extracorporeal membrane oxygenation [2]. Clinicians are alert to the possibility of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":448,"end":471},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma45662"}],"text":"The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which may require mechanical ventilation or extracorporeal membrane oxygenation [2]. Clinicians are alert to the possibility of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T4","span":{"begin":448,"end":471},"obj":"Body_part"},{"id":"T5","span":{"begin":454,"end":471},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"}],"text":"The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which may require mechanical ventilation or extracorporeal membrane oxygenation [2]. Clinicians are alert to the possibility of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T26","span":{"begin":4,"end":28},"obj":"Disease"},{"id":"T27","span":{"begin":30,"end":38},"obj":"Disease"},{"id":"T28","span":{"begin":159,"end":167},"obj":"Disease"},{"id":"T29","span":{"begin":188,"end":223},"obj":"Disease"},{"id":"T30","span":{"begin":194,"end":223},"obj":"Disease"},{"id":"T31","span":{"begin":225,"end":229},"obj":"Disease"},{"id":"T32","span":{"begin":250,"end":261},"obj":"Disease"},{"id":"T33","span":{"begin":417,"end":426},"obj":"Disease"},{"id":"T34","span":{"begin":472,"end":487},"obj":"Disease"},{"id":"T35","span":{"begin":478,"end":487},"obj":"Disease"},{"id":"T36","span":{"begin":550,"end":558},"obj":"Disease"},{"id":"T37","span":{"begin":626,"end":635},"obj":"Disease"},{"id":"T38","span":{"begin":651,"end":659},"obj":"Disease"},{"id":"T39","span":{"begin":681,"end":694},"obj":"Disease"},{"id":"T40","span":{"begin":696,"end":700},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0043905"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"}],"text":"The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which may require mechanical ventilation or extracorporeal membrane oxygenation [2]. Clinicians are alert to the possibility of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T10","span":{"begin":40,"end":45},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T11","span":{"begin":53,"end":54},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T12","span":{"begin":335,"end":343},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T13","span":{"begin":430,"end":431},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T14","span":{"begin":448,"end":471},"obj":"http://purl.obolibrary.org/obo/UBERON_0001558"},{"id":"T15","span":{"begin":502,"end":503},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which may require mechanical ventilation or extracorporeal membrane oxygenation [2]. Clinicians are alert to the possibility of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":568,"end":581},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":"The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which may require mechanical ventilation or extracorporeal membrane oxygenation [2]. Clinicians are alert to the possibility of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":472,"end":487},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which may require mechanical ventilation or extracorporeal membrane oxygenation [2]. Clinicians are alert to the possibility of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated."}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":0,"end":151},"obj":"Sentence"},{"id":"T9","span":{"begin":152,"end":360},"obj":"Sentence"},{"id":"T10","span":{"begin":361,"end":594},"obj":"Sentence"},{"id":"T11","span":{"begin":595,"end":728},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which may require mechanical ventilation or extracorporeal membrane oxygenation [2]. Clinicians are alert to the possibility of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":194,"end":214},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which may require mechanical ventilation or extracorporeal membrane oxygenation [2]. Clinicians are alert to the possibility of bacterial co-infection as a complication of lower respiratory tract viral infection; for example, a recent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated."}